Why most RTs never consider it. RT training emphasizes acute care. Most clinical rotations are in hospital settings. The outpatient pulmonary clinic is perceived as lower-acuity — and therefore lower-interest — by many practitioners who trained in the ICU. That perception is wrong. Outpatient RT in a pulmonary clinic involves spirometry, full pulmonary function testing, bronchoprovocation testing, six-minute walk test administration, inhaler technique assessment, CPAP and PAP follow-up, and pulmonary rehabilitation oversight.
The scope in a pulmonary clinic. Outpatient RTs perform and interpret spirometry before physician review, identify obstructive and restrictive patterns, flag reversibility, and flag quality issues that affect test validity. They conduct full pulmonary function testing including DLCO and lung volumes. They educate patients on inhaler technique in a setting where there is actually time to ensure understanding. They follow CPAP compliance data and adjust therapy.
The salary and schedule picture. Outpatient RT roles typically offer Monday through Friday schedules with no nights, no weekends, and no on-call. Compensation is generally 10 to 15 percent below hospital median. For RTs prioritizing quality of life and professional sustainability over maximum compensation after years of rotating shift work, the outpatient model is worth serious consideration.
How to get there: PFT-specific training is the primary credential gap for most ICU RTs considering outpatient work. Look for pulmonary function technologist training programs or request mentored time in your hospital’s PFT lab as a bridge into outpatient practice.
Why this matters for RTs specifically. The bedside chest X-ray on your ventilated patient is read by radiology — but the read comes hours later. The RT managing that patient at 0300 has the image on the workstation right now. An RT who can identify pneumothorax, significant effusion, ETT position, and consolidation patterns can act on that information immediately rather than waiting for the formal read.
The five things RTs should be looking at. (1) ETT position — tip should sit 3 to 5 cm above the carina. (2) Pneumothorax — absent lung markings at the periphery, especially apex in upright patients or deep sulcus sign supine. (3) Effusion — blunting of costophrenic angle or meniscus sign. (4) Consolidation pattern — air bronchograms within opacity suggest alveolar filling. (5) Overall lung field symmetry — asymmetric haziness that changed from the prior image tells you something changed clinically.
The practical limit. RT bedside X-ray interpretation is a clinical safety screen, not a diagnostic read. An RT who identifies a concern communicates it to the physician team immediately and escalates. The RT does not interpret and close.
How to build this skill: Ask your radiologist or pulmonologist to walk you through one CXR from your patients per week for three months. By week twelve you will have reviewed 36 chest X-rays with expert guidance. Most radiology departments agree to brief teaching rounds with RTs when asked directly.
The biologic landscape in 2026. Approved biologic agents for severe asthma include: omalizumab (anti-IgE), mepolizumab and benralizumab (anti-IL-5 pathway), dupilumab (anti-IL-4/IL-13), and tezepelumab (anti-TSLP). Tezepelumab is the broadest in application — it reduces severe exacerbations across eosinophilic and non-eosinophilic phenotypes, working in patients who would not respond to the eosinophil-targeting agents.
Key education points for biologic-treated asthma patients. Biologics are maintenance therapy — they do not replace rescue inhalers. Response is typically seen over 3 to 6 months — not immediately after the first dose. Maintenance inhaler regimen continues alongside the biologic. Missed doses matter — the anti-inflammatory benefit accumulates with consistent administration.
Why RTs specifically need to know this. RTs who manage asthma patients in clinic, ED, and inpatient settings are increasingly likely to encounter patients on biologic therapy. Understanding which agent the patient is on, what phenotype it targets, and whether adherence is an issue requires the same clinical depth as knowing their inhaler regimen. The biologic is now part of the medication history that matters to the RT assessment.
The education gap: Patients starting biologic therapy have often tried and failed multiple inhaler regimens and are skeptical, scared of injections, and confused about why they are being given a monthly shot instead of a different inhaler. The RT who can explain the mechanism clearly — a monthly injection that reduces the immune response driving their asthma inflammation — builds the patient trust that drives adherence.
What a professional development portfolio is. A curated, living document of your clinical competencies, professional activities, and outcomes evidence. Not a resume. A resume lists jobs and credentials. A portfolio is evidence of what you actually did and what it produced — clinical outcomes you influenced, protocols you developed, training you delivered, quality improvement projects you participated in, and CE you completed. It is the document that makes the case for promotion, salary increase, or a leadership role.
What to include. Clinical outcomes you can quantify. CE and credentialing records — every CRCE hour, every credential exam, every conference attended. Professional activities — committee membership, preceptorship, presentations, publications. Peer feedback — specific documented positive feedback from physicians, nurses, and patients. Quality improvement participation with your specific contribution and the outcome documented.
Why most RTs do not have one. Nobody in RT education tells you to build one. Most facilities do not require it for merit reviews. The result: most RTs accumulate years of meaningful clinical and professional work with no documentation — and then cannot articulate their value when a leadership opportunity or salary negotiation arises.
Where to keep it: A simple binder or shared Google Drive folder works. Format matters less than the habit. Start now with what you have — credentials, CE records, any outcome data you can access. Add to it quarterly. In two years you will have a document that demonstrates clinical depth no resume captures.
Next: Steroid therapy in ARDS 2026 — dexamethasone, methylprednisolone, and what the current evidence supports.
Soon: Extubation readiness — a systematic bedside framework that goes beyond the SBT.
On deck: Ventilator mode selection — PRVC vs PC vs VC and when each makes clinical sense.
Staying at the vent,
15 years across academic medical centers & community hospitals
